New insights into adaptive immunity in chronic neuroinflammation (Q36991434)

17 August 2017

1 reference

title

New insights into adaptive immunity in chronic neuroinflammation (English)

1 reference

17 August 2017

0 references

4

Frauke Zipp

0 references

author name string

Volker Siffrin

series ordinal

1

1 reference

PubMed ID

17981203

17 August 2017

Alexander U Brandt

series ordinal

2

1 reference

PubMed ID

17981203

17 August 2017

Josephine Herz

series ordinal

3

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

Advances in Immunology

1 reference

17 August 2017

96

1 reference

17 August 2017

1-40

1 reference

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Death ligands and autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Persistence of DNA Sequences of BK Virus and JC Virus in Normal Human Tissues and in Diseased Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

An open label study of the effects of rituximab in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Immunotherapy of experimental autoimmune encephalomyelitis (EAE): Differential effect of anti-IL-2 receptor antibody therapy on actively induced and T-line mediated EAE of the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Self-limitation of Th1-mediated inflammation by IFN-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

B cells regulate autoimmunity by provision of IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Neuronal FasL induces cell death of encephalitogenic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Mechanism of action of mitoxantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Rituximab: ongoing and future clinical development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

What do we know about the mechanism of action of disease-modifying treatments in MS?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Leukocyte traffic in the central nervous system: the participants and their roles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Analysis of regulatory CD8 T cells in Qa-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Microbial lipopeptides induce the production of IL-17 in Th cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Evidence for a prolonged role of alpha 4 integrin throughout active experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Suppression of experimental autoimmune neuritis by leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Intrathecal antibody production in a mouse model of Lyme neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Acute disseminated encephalomyelitis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Natalizumab effects on immune cell responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Competence and competition: the challenge of becoming a long-lived plasma cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Three or more routes for leukocyte migration into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Chimeric cytotoxin IL2-PE40 inhibits relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Chemoattractants and their receptors in homeostasis and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Safety of rosuvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

T-lymphocyte subsets in the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Multiple sclerosis☆Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The expression and function of chemokines involved in CNS inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Herpes simplex virus encephalitis: Intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Atorvastatin induces T cell anergy via phosphorylation of ERK1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

Blockade of chemokine signaling in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2807%2996001-0

7 January 2021

10.1016/S0065-2776(07)96001-0

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17981203